Stocks and Finance

United Therapeutics

United Therapeutics 4/12/2012

10:40 : United Therapeutics ([[UTHR]] -2.6%) shares are downgraded to Market Perfo - United Therapeutics (UTHR -2.6%) shares are downgraded to Market Perform from Outperform with a new price target of $48 from $65 by Leerink Swann, which cites generic risk to its treatment of pulmonary arterial hypertension. ...
Source : seekingalpha-com

United Therapeutics 3/15/2012

07:28 : United Therapeutics (UTHR) files a patent infringement lawsuit against ... - United Therapeutics (UTHR) files a patent infringement lawsuit against Novartis' (NVS) Sandoz unit over patents related to a pulmonary hypertension drug. Sandoz aims to sell a generic version of United's Remdoulin drug. NVS ...
Source : seekingalpha-com

United Therapeutics 12/27/2011

11:18 : United Therapeutics ([[UTHR]] -0.7%) says its wholly owned subsidiary, ... - United Therapeutics (UTHR -0.7%) says its wholly owned subsidiary, United Therapeutics Europe, has received approval from French regulators for its New Drug Application for Intravenous Remodulin for ...
Source : seekingalpha-com
actualidad United Therapeutics -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts